EUVIMEDEUVIMED entdecken
Crossref

Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes

Kamal Abi Mosleh, Jack W Sample, Amanda Belluzzi, Katarzyna Bartosiak, Davekaran Buttar, Richard S Betancourt, Aleksandra Kukla, Tayyab S Diwan, Omar M Ghanem iD

Surgical Endoscopy · 2024

DOI: 10.1007/s00464-024-10983-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Kamal Abi Mosleh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Bariatric Surgery, Postoperative Complications. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Obesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and bariatric surgery (MBS), including procedures such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), is a potential intervention for these individuals. However, the heightened risk of postoperative complications casts doubts on the suitability of MBS in this population. Our aim is to evaluate the long-term safety, anthropometric and renal outcomes of MBS in patients with CKD. METHODS: A retrospective review of patients who underwent primary laparoscopic MBS with a BMI ≥ 35 kg/m2 and a preoperative diagnosis of stage 2 to 5 CKD. Criteria for CKD diagnosis and staging were based on estimated glomerular filtration rate measurements in accordance with established guidelines. Anthropometric and renal outcomes were measured at 3-, 6-, 12-, 24- and 60-months postoperatively. RESULTS: A total of 302 patients (177 SG, 125 RYGB) were included. RYGB was preferred for patients with stage 3 CKD, while SG was more common in stages 4 and 5. At 5-year follow-up, percentage of total weight loss was higher in the RYGB cohort compared to SG (25.1% vs. 18.6%, p = 0.036). Despite SG patients having more advanced CKD, the incidence of late complications was significantly higher following RYGB, with 11 incidents (8.8%), compared to the SG cohort with only 4 cases (2.3%) (p = 0.014). In those with preoperative CKD stage 3, 76 patients (43.2%) improved to stage 2, with another 9 patients (5.1%) improving further to stage 1. Of all patients, 63 (20.8%) eventually received a successful renal transplant. CONCLUSIONS: MBS is an effective strategy for sustained weight loss in patients with CKD with acceptable complications rates. RYGB leads to a higher percentage of overall weight loss, albeit with an elevated likelihood of late surgical complications. Future studies are needed to determine the safety of MBS in this demographic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicBariatric SurgeryPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultWeight LossTreatment OutcomeGastric BypassLaparoscopyGlomerular Filtration RateObesity, MorbidGastrectomyFollow-Up Studies

Stichwörter der Autor:innen

Chronic kidney diseaseMetabolic and bariatric surgeryRenal transplantationRoux-en-Y gastric bypassSleeve gastrectomyWeight loss

Autor:innen und Institutionen

  • Department of Surgery, Mayo Clinic, Rochester, MN, USA.
  • Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Transplantation Surgery, Von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA.
  • Department of Surgery, Mayo Clinic, Rochester, MN, USA. Ghanem.omar@mayo.edu.
  • Division of Metabolic and Abdominal Wall Reconstructive Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Ghanem.omar@mayo.edu.

ORCID-Profile: Omar M Ghanem

Zitieren

APA

Abi Mosleh, K., Sample, J. W., Belluzzi, A., Bartosiak, K., Buttar, D., Betancourt, R. S., Kukla, A., Diwan, T. S., & Ghanem, O. M. (2024). Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10983-9

Vancouver

Abi Mosleh K, Sample JW, Belluzzi A, Bartosiak K, Buttar D, Betancourt RS, et al. Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10983-9

BibTeX
@article{AbiMosleh2024,
  author = {Abi Mosleh, Kamal and Sample, Jack W and Belluzzi, Amanda and Bartosiak, Katarzyna and Buttar, Davekaran and Betancourt, Richard S and Kukla, Aleksandra and Diwan, Tayyab S and Ghanem, Omar M},
  title = {Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes},
  journal = {Surgical Endoscopy},
  year = {2024},
  doi = {10.1007/s00464-024-10983-9}
}
Kostenlos starten →